Role of NK Cell Receptors in Acute Lymphoblastic Leukemia in Children

[1]  M. Hallek,et al.  Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity. , 2013, Blood.

[2]  N. Stanietsky,et al.  Recognition and Prevention of Tumor Metastasis by the NK Receptor NKp46/NCR1 , 2012, The Journal of Immunology.

[3]  Jan Tavernier,et al.  Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors , 2011, Nature Medicine.

[4]  Charles C. Kim,et al.  NK Cells and Immune “Memory” , 2011, The Journal of Immunology.

[5]  C. Pui,et al.  High-risk childhood acute lymphoblastic leukemia. , 2009, Clinical lymphoma & myeloma.

[6]  D. Campana,et al.  2B4 (CD244) Signaling by Recombinant Antigen-specific Chimeric Receptors Costimulates Natural Killer Cell Activation to Leukemia and Neuroblastoma Cells , 2009, Clinical Cancer Research.

[7]  Eric Vivier,et al.  The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans , 2009, The Journal of experimental medicine.

[8]  P. Mathew,et al.  Functional role of human NK cell receptor 2B4 (CD244) isoforms , 2009, European journal of immunology.

[9]  Lukasz K. Chlewicki.  Response to Comment on “Molecular Basis of the Dual Functions of 2B4 (CD244)” , 2008, The Journal of Immunology.

[10]  N. Munshi,et al.  Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu. , 2008, Blood.

[11]  F. Zhan,et al.  CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma , 2008, Clinical Cancer Research.

[12]  C. Demanet,et al.  NK cell receptors and their ligands in leukemia , 2008, Leukemia.

[13]  P. Mathew,et al.  CS1 (CRACC, CD319) Induces Proliferation and Autocrine Cytokine Expression on Human B Lymphocytes1 , 2007, The Journal of Immunology.

[14]  M. Weller,et al.  Malignant glioma cells counteract antitumor immune responses through expression of lectin-like transcript-1. , 2007, Cancer research.

[15]  Stefano Papa,et al.  NK Cells and Cancer1 , 2007, The Journal of Immunology.

[16]  D. Raulet.  Missing self recognition and self tolerance of natural killer (NK) cells. , 2006, Seminars in immunology.

[17]  D. Olive,et al.  Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma , 2006, Leukemia.

[18]  L. Lanier,et al.  Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor1 , 2005, The Journal of Immunology.

[19]  Megan E. McNerney,et al.  Targeted Disruption of the 2B4 Gene in Mice Reveals an In Vivo Role of 2B4 (CD244) in the Rejection of B16 Melanoma Cells1 , 2005, The Journal of Immunology.

[20]  Lewis L Lanier,et al.  NK cell recognition. , 2005, Annual review of immunology.

[21]  Eric Vivier,et al.  Natural Killer Cell Signaling Pathways , 2004, Science.

[22]  M. Korc,et al.  Membrane-Associated Heparan Sulfate Proteoglycans Are Involved in the Recognition of Cellular Targets by NKp30 and NKp461 , 2004, The Journal of Immunology.

[23]  Megan E. McNerney,et al.  2B4 Acts As a Non–Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells , 2004, The Journal of experimental medicine.

[24]  D. Olive,et al.  Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. , 2002, Blood.

[25]  M. Colonna,et al.  Cutting Edge: Activation of NK Cell-Mediated Cytotoxicity by a SAP-Independent Receptor of the CD2 Family1 , 2001, The Journal of Immunology.

[26]  M. Bennett,et al.  2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes , 2001, Immunological reviews.

[27]  M. Colonna,et al.  Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. , 1999, Tissue antigens.

[28]  M. Colonna,et al.  Activating interactions in human NK cell recognition: the role of 2B4‐CD48 , 1999, European journal of immunology.

[29]  C. Pui.  Acute lymphoblastic leukemia. , 1997, Pediatric clinics of North America.

[30]  J. Szer,et al.  Loss of natural killer activity as an indicator of relapse in acute leukaemia , 1990, Clinical and experimental immunology.

[31]  W. Murphy,et al.  Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID). Evidence that natural killer cells can mediate the specificity of marrow graft rejection , 1987, The Journal of experimental medicine.